Cognitive function and dementia in hypertension: Epidemiologic and therapeutic aspects

Jun Hata, Hisatomi Arima, Craig S. Anderson, John Chalmers

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hypertension and dementia are both common and increasingly important disorders in aging populations. As the two most common causes of dementia, Alzheimer's disease and vascular dementia often overlap and share vascular risk factors including hypertension, there is strong potential for blood pressure-lowering treatment to reduce the risks of dementia and cognitive decline. In this chapter, we review observational studies and randomized trials that have investigated blood pressure and the effects of blood pressure-lowering treatment on the risk of dementia or cognitive impairment. Observational studies indicate that high levels of blood pressure in midlife (40-64 years) predict dementia in later life, particularly vascular dementia, although the role of high blood pressure specifically in late-life (≥65 years) remains uncertain. Although several observational studies suggest protective effects of blood pressure-lowering treatment on the risk of dementia, the totality of the randomized evidence is still insufficient to confirm the potential for modest benefits of blood pressure-lowering on dementia. However, given the direct effects of blood pressure-lowering in reducing the risk of stroke and of stroke-associated dementia, it seems reasonable to propose that as more evidence accrues, blood pressure-lowering will at least be shown to have beneficial effects on vascular dementia and possibly on Alzheimer's disease, too.

Original languageEnglish
Title of host publicationSpecial Issues in Hypertension
PublisherSpringer-Verlag Italia s.r.l.
Pages399-412
Number of pages14
ISBN (Electronic)9788847026018
ISBN (Print)8847026008, 9788847026001
DOIs
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Cognition
Dementia
Hypertension
Blood Pressure
Vascular Dementia
Observational Studies
Alzheimer Disease
Therapeutics
Stroke
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hata, J., Arima, H., Anderson, C. S., & Chalmers, J. (2012). Cognitive function and dementia in hypertension: Epidemiologic and therapeutic aspects. In Special Issues in Hypertension (pp. 399-412). Springer-Verlag Italia s.r.l.. https://doi.org/10.1007/978-88-470-2601-8_30

Cognitive function and dementia in hypertension : Epidemiologic and therapeutic aspects. / Hata, Jun; Arima, Hisatomi; Anderson, Craig S.; Chalmers, John.

Special Issues in Hypertension. Springer-Verlag Italia s.r.l., 2012. p. 399-412.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hata, J, Arima, H, Anderson, CS & Chalmers, J 2012, Cognitive function and dementia in hypertension: Epidemiologic and therapeutic aspects. in Special Issues in Hypertension. Springer-Verlag Italia s.r.l., pp. 399-412. https://doi.org/10.1007/978-88-470-2601-8_30
Hata J, Arima H, Anderson CS, Chalmers J. Cognitive function and dementia in hypertension: Epidemiologic and therapeutic aspects. In Special Issues in Hypertension. Springer-Verlag Italia s.r.l. 2012. p. 399-412 https://doi.org/10.1007/978-88-470-2601-8_30
Hata, Jun ; Arima, Hisatomi ; Anderson, Craig S. ; Chalmers, John. / Cognitive function and dementia in hypertension : Epidemiologic and therapeutic aspects. Special Issues in Hypertension. Springer-Verlag Italia s.r.l., 2012. pp. 399-412
@inbook{4f2a7986c3b3411ea1720357de7ee20b,
title = "Cognitive function and dementia in hypertension: Epidemiologic and therapeutic aspects",
abstract = "Hypertension and dementia are both common and increasingly important disorders in aging populations. As the two most common causes of dementia, Alzheimer's disease and vascular dementia often overlap and share vascular risk factors including hypertension, there is strong potential for blood pressure-lowering treatment to reduce the risks of dementia and cognitive decline. In this chapter, we review observational studies and randomized trials that have investigated blood pressure and the effects of blood pressure-lowering treatment on the risk of dementia or cognitive impairment. Observational studies indicate that high levels of blood pressure in midlife (40-64 years) predict dementia in later life, particularly vascular dementia, although the role of high blood pressure specifically in late-life (≥65 years) remains uncertain. Although several observational studies suggest protective effects of blood pressure-lowering treatment on the risk of dementia, the totality of the randomized evidence is still insufficient to confirm the potential for modest benefits of blood pressure-lowering on dementia. However, given the direct effects of blood pressure-lowering in reducing the risk of stroke and of stroke-associated dementia, it seems reasonable to propose that as more evidence accrues, blood pressure-lowering will at least be shown to have beneficial effects on vascular dementia and possibly on Alzheimer's disease, too.",
author = "Jun Hata and Hisatomi Arima and Anderson, {Craig S.} and John Chalmers",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-88-470-2601-8_30",
language = "English",
isbn = "8847026008",
pages = "399--412",
booktitle = "Special Issues in Hypertension",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - CHAP

T1 - Cognitive function and dementia in hypertension

T2 - Epidemiologic and therapeutic aspects

AU - Hata, Jun

AU - Arima, Hisatomi

AU - Anderson, Craig S.

AU - Chalmers, John

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Hypertension and dementia are both common and increasingly important disorders in aging populations. As the two most common causes of dementia, Alzheimer's disease and vascular dementia often overlap and share vascular risk factors including hypertension, there is strong potential for blood pressure-lowering treatment to reduce the risks of dementia and cognitive decline. In this chapter, we review observational studies and randomized trials that have investigated blood pressure and the effects of blood pressure-lowering treatment on the risk of dementia or cognitive impairment. Observational studies indicate that high levels of blood pressure in midlife (40-64 years) predict dementia in later life, particularly vascular dementia, although the role of high blood pressure specifically in late-life (≥65 years) remains uncertain. Although several observational studies suggest protective effects of blood pressure-lowering treatment on the risk of dementia, the totality of the randomized evidence is still insufficient to confirm the potential for modest benefits of blood pressure-lowering on dementia. However, given the direct effects of blood pressure-lowering in reducing the risk of stroke and of stroke-associated dementia, it seems reasonable to propose that as more evidence accrues, blood pressure-lowering will at least be shown to have beneficial effects on vascular dementia and possibly on Alzheimer's disease, too.

AB - Hypertension and dementia are both common and increasingly important disorders in aging populations. As the two most common causes of dementia, Alzheimer's disease and vascular dementia often overlap and share vascular risk factors including hypertension, there is strong potential for blood pressure-lowering treatment to reduce the risks of dementia and cognitive decline. In this chapter, we review observational studies and randomized trials that have investigated blood pressure and the effects of blood pressure-lowering treatment on the risk of dementia or cognitive impairment. Observational studies indicate that high levels of blood pressure in midlife (40-64 years) predict dementia in later life, particularly vascular dementia, although the role of high blood pressure specifically in late-life (≥65 years) remains uncertain. Although several observational studies suggest protective effects of blood pressure-lowering treatment on the risk of dementia, the totality of the randomized evidence is still insufficient to confirm the potential for modest benefits of blood pressure-lowering on dementia. However, given the direct effects of blood pressure-lowering in reducing the risk of stroke and of stroke-associated dementia, it seems reasonable to propose that as more evidence accrues, blood pressure-lowering will at least be shown to have beneficial effects on vascular dementia and possibly on Alzheimer's disease, too.

UR - http://www.scopus.com/inward/record.url?scp=84930841894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930841894&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-2601-8_30

DO - 10.1007/978-88-470-2601-8_30

M3 - Chapter

AN - SCOPUS:84930841894

SN - 8847026008

SN - 9788847026001

SP - 399

EP - 412

BT - Special Issues in Hypertension

PB - Springer-Verlag Italia s.r.l.

ER -